We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · September 06, 2022

New-Onset Atrial Fibrillation in Patients With Type 2 Diabetes Treated With Novel Glucose Level–Lowering Therapies

The Journal of Clinical Endocrinology and Metabolism

 

Additional Info

The Journal of Clinical Endocrinology and Metabolism
New-Onset Atrial Fibrillation in Patients With Type 2 Diabetes Treated With Novel Glucose-Lowering Therapies
J. Clin. Endocrinol. Metab. 2022 Aug 18;107(9)2493-2499, FC Hsiao, KC Yen, TF Chao, SW Chen, YH Chan, PH Chu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading